Overview

The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. In this study participants will be followed from the time of consent through the lifetime of the study (currently 3 years), unless the participant chooses to withdraw from the study. Collection of participant's medical history, including MS and treatment history, will be automated through extraction from the participant's electronic medical record (EMR) and other health information systems (for example, radiology). Participants will complete patient-reported outcomes (PROs) and other health-related information digitally. Participating participants will have access to their own data in an ongoing manner via a web-based Participant Portal.

Eligibility

Inclusion Criteria:

• Participants willing and able to provide written informed consent
• Participants willing to be contacted while participating in the study for recruitment into sub-studies that may be relevant to them
• Participants willing and able to complete PROs on a monthly basis and document events of interest as they occur
• Participants willing to participate in additional follow up at the site for at least three years

Exclusion Criteria:

• Unable to complete questionnaires in English
• Unable to consistently access the Internet
• Participants participating in interventional clinical drug trials at baseline